This duality of action justifies understanding the pathways activated by AHR signaling to specifically block the deleterious pathways while maintaining the beneficial ones, mainly in cardiovascular disease, the main complication of CKD [155]. The gene discussed is AHR; the disease is chronic kidney disease.